We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

ENG rs1060501410: Understanding This Genetic Variant

rs1060501410
Trait
Moderate evidenceGene: ENG

The rs1060501410 variant is a specific genetic change located within the ENG gene region. This gene is primarily known for its role in blood vessel development and is associated with hereditary conditions when specific mutations occur.

What each genotype means

A/ALower attention

Typical ENG variant profile

This genotype represents the most common form of the ENG gene region observed in general population studies. There is currently no specific clinical association or functional impact documented for this variant in major genomic databases.

This is the most frequently observed genotype across global populations.

A/GLower attention

Typical ENG variant profile

This genotype represents a heterozygous state for this variant in the ENG gene region. Current scientific literature does not associate this specific genetic change with any known clinical traits or health conditions.

This genotype is observed at a low frequency in the general population.

G/GLower attention

Typical ENG variant profile

This genotype represents the homozygous state for the minor allele of this variant. There is no evidence in current research to suggest that this genotype influences health or disease risk.

This genotype is rare and observed in a very small percentage of the population.

What is rs1060501410?

The identifier rs1060501410 refers to a single nucleotide polymorphism (SNP) located on chromosome 9 within the human genome. In the context of genetic research, SNPs are common variations where a single building block of DNA—a nucleotide—differs between individuals. This specific variant is situated in the region of the ENG gene, which provides the blueprint for the endoglin protein. While many variants in the human genome are neutral and have no observable effect on health, researchers track these specific markers to understand how genetic diversity influences biological processes. The rs1060501410 variant is cataloged in public databases that aggregate genomic data, allowing scientists to study its potential presence across different populations. It is important to note that being listed in a database does not imply that a variant causes disease; rather, it serves as a point of reference for ongoing genomic studies.

The Role of the ENG Gene

The ENG gene is responsible for producing a protein called endoglin. This protein is primarily found on the surface of cells that line the interior of blood vessels. Endoglin plays a critical role in the cardiovascular system by forming complexes with growth factors and other proteins that regulate the development and maintenance of blood vessels. Specifically, it is essential for the proper specialization of new blood vessels into arteries or veins. Because of its involvement in vascular integrity, mutations in the ENG gene are well-documented in medical literature for their link to hereditary hemorrhagic telangiectasia type 1 (HHT1), a condition characterized by abnormal blood vessel formation. While the gene is vital for vascular health, it is also being studied for its potential involvement in other areas, including preeclampsia and certain types of cancer, where cell growth and vascularization are key factors.

Research and Evidence

Current scientific evidence regarding rs1060501410 is limited. While the ENG gene itself is extensively studied due to its clear link to HHT1, the specific variant rs1060501410 does not currently have a strong, established association with a specific clinical trait or disease in major genome-wide association studies (GWAS). In genomics, many variants are identified during large-scale sequencing projects but remain classified as having unknown or neutral significance until further research provides evidence of a functional impact. The evidence strength for this specific SNP is considered moderate in some cataloging contexts, primarily because it resides in a gene of high clinical interest, rather than because it has been proven to cause a specific health outcome. Researchers continue to monitor such variants to see if future studies reveal correlations with metabolic or vascular traits, but at this time, no definitive medical conclusions can be drawn from its presence.

Population Frequency

Information regarding the frequency of the rs1060501410 variant across different global populations is not currently specified in major public genomic databases. Genetic frequency data is often ancestry-specific, and for many rare or less-studied variants, the data may not yet be robust enough to provide a clear percentage of how often the variant appears in the general population. As more individuals participate in large-scale genomic research, these frequency statistics are updated to provide a clearer picture of how common or rare a specific allele might be across diverse ancestral groups.

Interpreting Your Genetic Information

If you have encountered this variant in a personal genetic report, it is important to understand that this information is for educational purposes only. The presence of a variant in the ENG gene region does not constitute a medical diagnosis, nor does it predict the development of any specific condition. Because the ENG gene is associated with complex vascular processes, any concerns regarding your cardiovascular health or family history should be discussed with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your overall health, family history, and clinical symptoms. Never make changes to your health regimen or medication based on genetic data without consulting a professional. Genetic information is a tool for understanding biological potential, but it is only one piece of a much larger puzzle that includes your environment, lifestyle, and clinical history.

How common is this variant?

The population frequency for rs1060501410 is not currently specified in public genomic databases.

Frequently asked questions

Is rs1060501410 a disease-causing mutation?

No, there is no current evidence that rs1060501410 is a disease-causing mutation. While the ENG gene is associated with certain hereditary conditions, this specific variant is not currently linked to any clinical diagnosis.

Should I be worried if I have this variant?

There is no reason for concern based on this variant alone. Most genetic variants are neutral, and this specific SNP does not have a known impact on health.

Where can I find more information about the ENG gene?

You can find reliable, peer-reviewed information about the ENG gene and its functions on resources like MedlinePlus Genetics or the NCBI Gene database.

Does this variant affect how I respond to medication?

There is no evidence suggesting that rs1060501410 affects medication response. Always discuss any questions about your medications with your doctor or pharmacist.

Sources & further reading

Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs1060501410?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in ENG